Prolactin Adenomas in Senegal: Epidemiological, Diagnostic and Therapeutic Aspects of 89 Cases
- 1 Medical Clinic II, Abass Ndao Hospital Center, Cheikh Anta Diop University, Dakar, Senegal
- 2 Medical Clinic II, Abass Ndao Hospital Center, Cheikh Anta Diop University, Dakar, Senegal
- 3 Medical Clinic II, Abass Ndao Hospital Center, Cheikh Anta Diop University, Dakar, Senegal
- 4 Medical Clinic II, Abass Ndao Hospital Center, Cheikh Anta Diop University, Dakar, Senegal
- 5 Medical Clinic II, Abass Ndao Hospital Center, Cheikh Anta Diop University, Dakar, Senegal
- 6 Medical Clinic II, Abass Ndao Hospital Center, Cheikh Anta Diop University, Dakar, Senegal
- 7 Medical Clinic II, Abass Ndao Hospital Center, Cheikh Anta Diop University, Dakar, Senegal
- 8 Medical Clinic II, Abass Ndao Hospital Center, Cheikh Anta Diop University, Dakar, Senegal
- 9 Medical Clinic II, Abass Ndao Hospital Center, Cheikh Anta Diop University, Dakar, Senegal
- 10 Medical Clinic II, Abass Ndao Hospital Center, Cheikh Anta Diop University, Dakar, Senegal
- 11 Medical Clinic II, Abass Ndao Hospital Center, Cheikh Anta Diop University, Dakar, Senegal
- 12 Medical Clinic II, Abass Ndao Hospital Center, Cheikh Anta Diop University, Dakar, Senegal
- 13 Medical Clinic II, Abass Ndao Hospital Center, Cheikh Anta Diop University, Dakar, Senegal
- 14 Medical Clinic II, Abass Ndao Hospital Center, Cheikh Anta Diop University, Dakar, Senegal
- 15 Medical Clinic II, Abass Ndao Hospital Center, Cheikh Anta Diop University, Dakar, Senegal
Abstract
Introduction: In Senegal, there is very little data on prolactinomas despite their negative impact on couples fertility. Patients and methods: This was a multicentre, retrospective, descriptive, analytical study conducted from 1 January 2008 to 31 December 2022 in the neurosurgery departments of the Fann and Principal hospitals and the endocrinology department of the Abass Ndao Hospital. Results: We included 89 patients, representing a prevalence of 36.7% among all cases of pituitary adenoma. The mean age was 35.6 ± 10 years and the sex ratio was 0.34. The mean time to consultation was 27.1 ± 29 months. Clinical symptoms were dominated by gonadotropic disorders represented by galactorrhoea (71 cases, 79.8%), amenorrhoea (61 cases, 68.5%), and infertility in the couple (31 cases, 34.8%). Fifty-seven (58) patients presented with a tumour syndrome (65.2%, including 57 cases of headache (64%), 34 cases of visual disorders (38.2%) and 8 patients with a dysmorphic syndrome (8.9%). Imaging revealed a macroadenoma in 68.5% (61 cases) and extension of the adenoma in 11 patients (12.4%). The hormonal profile was isolated lactotropic hypersecretion (80 cases, 89.9%) and mixed in 9 cases (including concomitant secretion of GH in 8 cases and ACTH in 1 case). All patients had initially benefited? from dopaminergic agonist-based medical treatment. Pituitary surgery was effective in 45 patients (50.6%), including 44 cases by transsphenoidal approach. Postoperative incidents included transient diabetes insipidus (77.7%) and cerebrospinal fluid leakage (20%). We noted 7 cases (7.9%) of death presenting with a tumour syndrome (100%), a macro-adenoma (85.7%), having undergone pituitary surgery (42.9%). The factors significantly associated with prolactinoma were young age (p < 0.001), female sex (p < 0.001), long delay in consultation (p < 0.001) and a microadenoma (p < 0.001). Conclusion: This series also demonstrates the impact of prolactin adenomas on reproductive function. Delayed diagnosis explains the predominance of macroadenomas, which are a source of pre- and post-operative complications.
- Molitch, M.E. (2002) Prolactinoma. In: Melmed, S., Ed., The Pituitary, Blackwell, Hoboken, 455-495.
- Fernandez, A., Karavitaki, N. and Wass, J.A.H. (2010) Prevalence of Pituitary Adenomas: A Community-Based, Cross-Sectional Study in Banbury (Oxfordshire, UK). Clinical Endocrinology, 72, 377-382. https://doi.org/10.1111/j.1365-2265.2009.03667.x
- Daly, A.F., Rixhon, M., Adam, C., et al. (2006) High Prevalence of Pituitary Adenomas: A Cross-Sectional Study in the Province of Liege, Belgium. The Journal of Clinical Endocrinology & Metabolism, 91, 4769-4775. https://doi.org/10.1210/jc.2006-1668
- Kontogeorgos, G., Horvath, E., Kovacs, K., et al. (2005) Morphologic Changes of Prolactin-Producing Pituitary Adenomas after Short Treatment with Dopamine Agonists. Acta Neuropathologica, 111, 46-52. https://doi.org/10.1007/s00401-005-1111-8
- Diop, A.G., Ndiaye, M.M., Ndiaye, I.P., et al. (1990) Les adénomes à prolactine à Dakar. Dakar Médical, 35, 168-176.
- Raappana, A., Koivukangas, J., Ebeling, T. and Pirila, T. (2010) Incidence of Pituitary Adenomas in Northern Finland in 1992-2007. The Journal of Clinical Endocrinology & Metabolism, 95, 4268-4275. https://doi.org/10.1210/jc.2010-0537
- Fontana, E. and Gaillard, R. (2009) Epidemiology of Pituitary Adenoma: Results of the First Swiss Study. Revue Médicale Suisse, 5, 2172-2174.
- Gruppetta, M., Mercieca, C. and Vassallo, J. (2013) Prevalence and Incidence of Pituitary Adenomas: A Population-Based Study in Malta. Pituitary, 16, 545-553. https://doi.org/10.1007/s11102-012-0454-0
- Agustsson, T.T., Baldvinsdottir, T., Jonasson, J.G., et al. (2015) The Epidemiology of Pituitary Adenomas in Iceland, 1955-2012: A Nationwide Population-Based Study. European Journal of Endocrinology, 173, 655-664. https://doi.org/10.1530/EJE-15-0189
- Day, P.F., Loto, M.G., Glerean, M., et al. (2016) Incidence and Prevalence of Clinically Relevant Pituitary Adenomas: Retrospective Cohort Study in a Health Management Organization in Buenos Aires, Argentina. Archives of Endocrinology and Metabolism, 60, 554-561. https://doi.org/10.1590/2359-3997000000195
- Eloundou, N.J., Eyenga, V.C., Ngowe Ngowe, M., Atangana, R. and Sosso, M.A. (2009) Les adénomes hypophysaires. Etude d’une série chirurgicale de 16 cas à Yaoundé Cameroun. African Journal of Neurological Sciences, 28, 55-60.
- Abodo, J., Haidara, A., Koffi, D., et al. (2016) Profil des adénomes hypophysaires en Afrique subsaharienne à propos de 38 cas. Annales d’Endocrinologie, 77, 368-369. https://doi.org/10.1016/j.ando.2016.07.381